Paul Agapow

3 years ago By Amber Wareing
  • Share on

  • Linkedin

Originally a biochemist and immunologist, Paul moved sideways into computational biology, using it for infectious disease and precision medicine. After stints working at the Health Protection Agency and Imperial College London’s Data Science Institute, he has recently moved to the pharmaceutical sector where his work focuses on integrating real-world and molecular data for better therapeutics. Roundtable Discussion: How to Improving Drug Development and Clinical trials with Real World Evidence.

More news